Company Imagion Biosystems Limited
Equities
IBX
AU000000IBX6
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.082 AUD | 0.00% |
|
-7.87% | -76.90% |
02-29 | Imagion Biosystems Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
01-15 | Imagion Biosystems CEO Resigns | MT |
Business Summary
Sales per Business
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Research & Development
100.0
%
| 0 | 100.0 % | 1 | 100.0 % | +128.74% |
Sales per region
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 1 | 100.0 % | +128.74% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Robert Proulx
CHM | Chairman | 66 | - |
Carmen Soikowski
COO | Chief Operating Officer | - | 21-10-31 |
Marie Zhang
CTO | Chief Tech/Sci/R&D Officer | - | 18-01-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Ludvigson
BRD | Director/Board Member | 74 | 17-03-07 |
Robert Proulx
CHM | Chairman | 66 | - |
Michael Harsh
BRD | Director/Board Member | 69 | 17-02-27 |
Director/Board Member | - | 16-12-05 |
Company contact information
![address Imagion Biosystems Limited(IBX)](https://cdn.zonebourse.com/static/address/34912627.png)
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
-76.90% | 1.78M | |
-32.56% | 14.67B | |
-55.36% | 2.2B | |
+17.78% | 1.83B | |
-14.62% | 1.42B | |
+17.43% | 1.18B | |
-24.88% | 864M | |
+1.62% | 784M | |
-37.13% | 723M | |
+17.92% | 575M |
- Stock Market
- Equities
- IBX Stock
- Company Imagion Biosystems Limited